Skip to main content

Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH

  • Conference paper
NASH and Nutritional Therapy

Summary

To clarify the biochemical markers to discriminate between nonalcoholic steatohepatitis (NASH) and simple steatosis in Japanese patients and to clarify the clinicopathological features of NASH, we analyzed patients with NASH and simple fatty liver (FL). Seventy-five patients with biopsy-proven NASH and 53 patients with biopsy-proven FL were enrolled. Their clinical characteristics and histological findings were compared. Detection of GB virus (GBV) RNA and SEN virus (SENV) DNA was performed by polymerase chain reaction (PCR). Mutational analysis of the HFE gene was performed by PCR-restriction fragment length polymorphism. As a marker of oxidative stress, serum thioredoxin (TRX) levels were determined. Insulin resistance was evaluated by a homeostasis model assessment of insulin resistance (HOMAIR). Serum TRX levels were significantly elevated in patients with NASH, compared with patients with FL. GBV was detectable in the serum of only one patient with NASH. SEN virus was detected in 50% (15/30) of the patients tested, but the prevalence was not significantly different between the two groups (42% [8/19] in FL and 64% [7/11] in NASH). The HFE gene was not detected in any patient.We constructed a receiver operating characteristic (ROC) curve which confirmed that serum TRX and ferritin levels were predictors for distinguishing NASH from FL. HOMA-IR was higher in NASH patients than in FL patients. The pathogenesis of NASH may be associated with insulin resistance and iron-related oxidative stress. The serum TRX level is a parameter for discriminating NASH from simple steatosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Sanyal AJ (2002) Technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705–1725

    Article  PubMed  Google Scholar 

  2. Younossi ZM, Diehl AM, Ong JP (2002) Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 35: 746–752

    Article  PubMed  Google Scholar 

  3. Powell EE, Cooksley WGE, Hanson R, Searle J (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 11: 74–80

    PubMed  Google Scholar 

  4. Day CP, James OFW (1998) Steatohepatitis: a tale of two ‘hits’? Gastroenterology 114: 842–845

    Article  PubMed  CAS  Google Scholar 

  5. James O, Day C (1999) Non-alcoholic steatohepatitis: another disease of affluence. Lancet 353: 1634–1636

    PubMed  CAS  Google Scholar 

  6. George DK, Goldwurm S, Macdonald GA (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114: 311–318

    Article  PubMed  CAS  Google Scholar 

  7. Hirota K, Matsui M, Iwata S (1997) AP-1 transcription activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633–3638

    Article  PubMed  CAS  Google Scholar 

  8. Nakamura H, Nakamura K, Yodoi J (1997) Redox regulation of cellular activation. Annu Rev Immunol 15: 351–369

    Article  PubMed  CAS  Google Scholar 

  9. Linnen J, Wages J Jr, Zhang-Keck ZY (1996) Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505–508

    PubMed  CAS  Google Scholar 

  10. Simons JN, Leary TP, Dawson GJ (1995) Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1: 564–569

    Article  PubMed  CAS  Google Scholar 

  11. Kiyosawa K (1997) Non-alcoholic steatohepatitis and GB virus-C/hepatitis G virus infection: is there a causal relationship? Intern Med 36: 236–237

    PubMed  CAS  Google Scholar 

  12. Nishizawa T, Okamoto H, Konishi K (1997) A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241: 92–97

    Article  PubMed  CAS  Google Scholar 

  13. Tokita H, Murai S, Kamitsukasa H (2001) Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease. Hepatol Res 19: 197–211

    PubMed  Google Scholar 

  14. Primi D, Fiordalisi G, Mantero JL, Identification of SENV genotypes. International patent number WO0028039 (international application published under the patent cooperation treaty). http://ep.espacenet.com

    Google Scholar 

  15. Tanaka Y, Primi D, Wang RYH (2001) Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 183: 359–367

    Article  PubMed  CAS  Google Scholar 

  16. Umemura T, Yeo AET, Sottini A (2001) SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 33: 1303–1311

    Article  PubMed  CAS  Google Scholar 

  17. Brunt EM, Janney CG, DiBisceglie AM (2000) Nonalcoholic steatohepatitis: a proposal for grading and staging the histologic lesions. Am J Gastroenterol 94: 2467–2474

    Google Scholar 

  18. MacSween RNM, Anthony PP, Sheuer PJ (1987) Pathology of the liver. Churchill Livingstone, Edinburgh, p 185

    Google Scholar 

  19. Tan D, Matsumoto A, Conry-Cantilena C (1999) Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis 179: 1055–1061

    Article  PubMed  CAS  Google Scholar 

  20. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T (1998) The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116: 127–134

    Google Scholar 

  21. Matteoni CA, Younossi ZM, Gramlich T (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413–1419

    Article  PubMed  CAS  Google Scholar 

  22. Bacon BR, Farahvash MJ, Janney CG (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103–1109

    PubMed  CAS  Google Scholar 

  23. Sumida Y, Nakashima T, Yoh T (2003) Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 38: 32–38

    Article  PubMed  CAS  Google Scholar 

  24. Angulo P, Keach J, Batts K (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356–1362

    PubMed  CAS  Google Scholar 

  25. Mendler M, Turlin B, Moirand R (1999) Insulin resistance-associated hepatic iron overload. Gastroenterology 117: 1155–1163

    Article  PubMed  CAS  Google Scholar 

  26. Sohda T, Yanai J, Soejima H (1999) Frequencies in the Japanese population of HFE gene mutations. Biochem Genet 37: 63–68

    Article  PubMed  CAS  Google Scholar 

  27. Loguercio C, Girolamo V, Sio IF (2001) Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 35: 568–574

    Article  PubMed  CAS  Google Scholar 

  28. Powell EE, Kroon PA (1992) Liver, lipoproteins and disease: II. Clinical relevance of disordered cholesterol metabolism in liver disease. J Gastroenterol Hepatol 7: 225–231

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Tokyo

About this paper

Cite this paper

Okanoue, T., Yamauchi, N., Furutani, M., Hirohama, A., Sumida, Y., Nakashima, T. (2005). Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH. In: Okita, K. (eds) NASH and Nutritional Therapy. Springer, Tokyo. https://doi.org/10.1007/4-431-27172-4_5

Download citation

  • DOI: https://doi.org/10.1007/4-431-27172-4_5

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-21388-8

  • Online ISBN: 978-4-431-27172-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics